Objectives. The aim of the one-year study was to assess changes in nitroglycerin consumption and suffocating symptoms severity in relation to thepresence and severity of depressive and anxiety disorders in women with ischemic heart disease (IHD).
Method Participants in the study were female patients diagnosed with angina pectoris in the past year, successively admitted to one of several cardiologic outpatient clinics in Lodz. Three groups of 30patients each were enrolled: 1. IDH with no depressive disorders, 2. IHD with co-morbid depressive disorders treated with citalopram in therapeutic dosage, and 3. IHD with untreated depression. The suffocating symptoms severity was assessed using the Canadian Cardiologic Society (CCS) Angina Scale, nitroglycerin consumption - using a ąuestionnaire developed for thepurposes of the study, while depressive and anxiety disorders - using the Beck Depression Inventory (BDI), STAI-X1 and STAI-X2.
Results. Decrements in the number andseverity of depressive symptoms due to the one-year antidepressant treatment in IHD women were related to a significant positive outcome: diminished nitroglycerin consumption and suffocating symptoms severity. This was correlated with a significant decrement in trait and state anxiety levels.